1. Detection of Demodex folliculorum from nipple discharge. Issue 3 (26th February 2013) Authors: Yokoyama, Toshiro; Yamaguchi, Rin; Itoh, Tsutomu; Toh, Uhi; Nakagawa, Shino; Kage, Masayoshi Journal: Diagnostic cytopathology Issue: Volume 42:Issue 3(2014:Mar.) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diverse histomorphology of HER2‐positive breast carcinomas based on differential ER expression. Issue 4 (3rd February 2020) Authors: Akashi, Momoko; Yamaguchi, Rin; Kusano, Hironori; Obara, Hitoshi; Yamaguchi, Miki; Toh, Uhi; Akiba, Jun; Kakuma, Tatsuyuki; Tanaka, Maki; Akagi, Yoshito; Yano, Hirohisa Journal: Histopathology Issue: Volume 76:Issue 4(2020) Page Start: 560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer. Issue 8 (25th June 2020) Authors: Toh, Uhi; Sakurai, Sayaka; Saku, Shuko; Takao, Yuko; Okabe, Mina; Iwakuma, Nobutaka; Shichijo, Shigeki; Yamada, Akira; Itoh, Kyogo; Akagi, Yoshito Journal: Cancer science Issue: Volume 111:Issue 8(2020) Page Start: 2760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A11+ or ‐A33+ allele. Issue 4 (21st April 2017) Authors: Sakamoto, Shinjiro; Matsueda, Satoko; Takamori, Shinzo; Toh, Uhi; Noguchi, Masanori; Yutani, Shigeru; Yamada, Akira; Shichijo, Shigeki; Yamada, Teppei; Suekane, Shigetaka; Kawano, Kouichiro; Naitou, Masayasu; Sasada, Tetsuro; Hattori, Noboru; Kohno, Nobuoki; Itoh, Kyogo Journal: Cancer science Issue: Volume 108:Issue 4(2017) Page Start: 598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunological evaluation of peptide vaccination for cancer patients with the HLA‐A26 allele. Issue 10 (25th September 2015) Authors: Sakamoto, Shinjiro; Matsueda, Satoko; Takamori, Shinzo; Toh, Uhi; Noguchi, Masanori; Yutani, Shigeru; Yamada, Akira; Shichijo, Shigeki; Yamada, Teppei; Suekane, Shigetaka; Kawano, Kouichiro; Sasada, Tetsuro; Hattori, Noboru; Kohno, Nobuoki; Itoh, Kyogo Journal: Cancer science Issue: Volume 106:Issue 10(2015:Oct.) Page Start: 1257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OR128 CTL AND IGG RESPONSE TO TUMOR-ASSOCIATED ANTIGENS AS PREDICTIVE FACTORS OF THERAPEUTIC PEPTIDE VACCINATION FOR PATIENTS WITH METASTATIC RECURRENT BREAST CANCER. (November 2015) Authors: Toh, Uhi; Okabe, Mina; Iwakuma, Nobutaka; Mishima, Mai; Shijijo, Shigeki; Yamada, Akira; Itoh, Kyogo; Akagi, Yoshito Journal: Breast Issue: Volume 24(2015)Supplement 3 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Predictive factors of the tumor immunological microenvironment for long‐term follow‐up in early stage breast cancer. Issue 1 (21st January 2017) Authors: Okabe, Mina; Toh, Uhi; Iwakuma, Nobutaka; Saku, Shuko; Akashi, Momoko; Kimitsuki, Yuko; Seki, Naoko; Kawahara, Akihiko; Ogo, Etsuyo; Itoh, Kyogo; Akagi, Yoshito Journal: Cancer science Issue: Volume 108:Issue 1(2017) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial. Issue 5 (May 2022) Authors: Saji, Shigehira; Taira, Naruto; Kitada, Masahiro; Takano, Toshimi; Takada, Masahiro; Ohtake, Tohru; Toyama, Tatsuya; Kikawa, Yuichiro; Hasegawa, Yoshie; Fujisawa, Tomomi; Kashiwaba, Masahiro; Ishida, Takanori; Nakamura, Rikiya; Yamamoto, Yutaka; Toh, Uhi; Iwata, Hiroji; Masuda, Norikazu; Morita, ... Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: 636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. YB-1 prevents apoptosis via the mTOR/STAT3 pathway in HER-2-overexpressing breast cancer cells. (March 2009) Authors: Fujii, Teruhiko; Seki, Naoko; Namoto-Matsubayashi, Roka; Takahashi, Hiroki; Inoue, Yuka; Toh, Uhi; Kage, Masayoshi; Shirouzu, Kazuo Journal: Future oncology Issue: Volume 5:Number 2(2009) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗